Art

J-GLOBAL ID：201602284483697042   Reference number：16A1349008

当科におけるセツキシマブの有効性に関する検討

Author (8)： TSUJI AKIRA (金沢大学附属病院耳鼻咽喉科頭頸部外科) ,  UENO TAKAYOSHI (金沢大学附属病院耳鼻咽喉科頭頸部外科) ,  NAKANISHI YOSUKE (金沢大学附属病院耳鼻咽喉科頭頸部外科) ,  ENDO KAZUHIRA (金沢大学附属病院耳鼻咽喉科頭頸部外科) ,  KONDO SATORU (金沢大学附属病院耳鼻咽喉科頭頸部外科) ,  WAKISAKA NAOHIRO (金沢大学附属病院耳鼻咽喉科頭頸部外科) ,  MURONO SHIGEYUKI (金沢大学附属病院耳鼻咽喉科頭頸部外科) ,  YOSHIZAKI TOMOKAZU (金沢大学附属病院耳鼻咽喉科頭頸部外科)
Material： 頭頸部癌  (頭けい部癌)
Volume： 42  Issue： 1  Page： 76-80(J-STAGE)  Publication year： 2016 
JST Material Number： Y0503A  ISSN： 1349-5747  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Cetuximab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1349008&from=J-GLOBAL&jstjournalNo=Y0503A") }}

Author keywords (6)： 頭頸部癌 ,  セツキシマブ ,  間質性肺炎 ,  Head and neck cancer ,  Cetuximab ,  Interstitial pneumonia

JST classification (3)： Tumors(=neoplasms)of ear,nose,pharynx and larynx  (GQ04000E) ,  Tumors(=neoplasms)of tooth and mouth(=oral cavity)  (GT04000N) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (9)：

• 1) Bonner J.A., Harari P.M., Giralt J., et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578, 2006
• 2) Vermorken J.B., Mesia R., Rivera F., et al: Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116-1127, 2008
• 3) Okano S., Yoshino T., Fujii M., et al: Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck. Jpn J Clin Oncol 43:476-482, 2013
• 4) Yoshino T., Hasegawa Y., Takahashi S., et al: Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: result of a phase II trial. Jpn J Clin Oncol 43:524-531, 2013
• 5) Siena S., Glynne-Jones R., Adenis A., et al: Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication. Cancer 116:1827-1837, 2010

Terms in the title (2)： セツキシマブ ,  有効性